Beijing, China

Youlin Liu

This inventor holds 1 USPTO granted patent. Top assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Youlin Liu: Innovator in Flow Cytometry Technology

Introduction

Youlin Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of flow cytometry, particularly through his innovative patent that enhances the accuracy of cell population analysis. His work is vital for advancements in biomedical research and diagnostics.

Latest Patents

Youlin Liu holds a patent for an "Automatic compensation method, device, and corresponding flow cytometer." This invention provides automatic compensation methods and devices that improve the precision of flow cytometry. The method involves determining a base cell population and a reference cell population, calculating a compensation value through a progressive approximation algorithm, and updating the dot plot to ensure that the position difference between the populations is within a predetermined range. This innovation is crucial for accurate cell analysis in various research applications.

Career Highlights

Youlin Liu is associated with Shenzhen Mindray Bio-medical Electronics Co., Ltd., a leading company in the biomedical field. His work at Mindray has allowed him to contribute to the development of advanced medical technologies that benefit healthcare professionals and researchers alike.

Collaborations

Youlin Liu has collaborated with notable colleagues, including Penghao Liu and Wenheng Guo. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Youlin Liu's contributions to flow cytometry through his innovative patent demonstrate his commitment to advancing biomedical technology. His work continues to impact the field positively, paving the way for future innovations in cell analysis.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…